Anastrazole 25tab/1mg Anastrazole – Magnus
Anastrazole 25tab/1mg (Magnus) is a potent aromatase inhibitor that reduces estrogen by >80% in postmenopausal women with advanced breast cancer.
Key Features:
- Effective hormonal suppression
- Targeted for post‑menopausal use
- Once‑daily oral dosing
- Well‑studied safety profile
Magnus Anastrozole 25 Tab / 1 mg – Targeted Hormone Therapy for Breast Cancer
Key Features of Magnus Anastrozole
- Brand name: Magnus
- Formulation: 1 mg tablets, 25‑tablet bottle
- Indication: Postmenopausal women with advanced estrogen‑dependent breast cancer progressing after tamoxifen
- Mechanism of action: Selective aromatase inhibition – blocks conversion of androgens to estrogens, reducing circulating estrogen by >80%
- Prescription status: Prescription only
Administration Guidelines
- Take one tablet orally once daily, preferably at the same time each day.
- Can be taken with or without food; avoid alcohol to reduce nausea risk.
- Continue therapy as directed by your oncologist; do not discontinue abruptly.
- If a dose is missed, take it as soon as remembered unless close to next scheduled dose.
Common Side Effects
| Side Effect | Frequency |
|---|---|
| Hot flashes | Mild–moderate in ~30% |
| Joint pain (arthralgia) | ~15‑20% |
| Fatigue | ~10‑12% |
| Bone density loss / osteoporosis risk | Long‑term use may increase risk; monitor with DEXA scans. |
| Headache | ~5‑8% |
| Gastrointestinal upset (nausea, diarrhea) | Rare (<2%) |
Precautions & Contraindications
- Not recommended for premenopausal women due to severe hormonal side effects.
- Avoid if you have a history of uncontrolled hypertension or cardiovascular disease without medical supervision.
- Discuss bone health; consider calcium and vitamin D supplementation.
How PoseidonRX Supports Your Treatment
PoseidonRX offers reliable delivery of Magnus Anastrozole, ensuring you receive the medication promptly for continuous care in your breast cancer journey.


There are no reviews yet.